deferoxamine has been researched along with natriuretic peptide, brain in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, LJ; Dessi, C; Galanello, R; Nair, SV; Pennell, DJ; Smith, GC; Tanner, MA; Walker, JM; Westwood, MA | 1 |
| Agus, A; Dessi, C; Galanello, R; Nair, SV; Pennell, DJ; Pibiri, M; Smith, GC; Tanner, MA; Walker, JM; Westwood, MA | 1 |
| Tan, T; Weiss, HR | 1 |
| Scholz, PM; Tan, T; Weiss, HR | 1 |
1 trial(s) available for deferoxamine and natriuretic peptide, brain
| Article | Year |
|---|---|
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.
Topics: Administration, Oral; Adult; beta-Thalassemia; Cardiomyopathies; Deferiprone; Deferoxamine; Drug Therapy, Combination; Female; Ferritins; Humans; Injections, Subcutaneous; Iron; Iron Chelating Agents; Italy; Liver; Magnetic Resonance Imaging; Male; Myocardium; Natriuretic Peptide, Brain; Prospective Studies; Pyridones; Severity of Illness Index; Siderosis; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2008 |
3 other study(ies) available for deferoxamine and natriuretic peptide, brain
| Article | Year |
|---|---|
Myocardial iron loading in patients with thalassemia major on deferoxamine chelation.
Topics: beta-Thalassemia; Cardiomyopathies; Chi-Square Distribution; Deferoxamine; Female; Ferritins; Humans; Iron Overload; Italy; Magnetic Resonance Imaging; Male; Myocardium; Natriuretic Peptide, Brain; Prevalence; Siderophores; Ventricular Dysfunction, Left | 2006 |
Hypoxia inducible factor-1 protects against nitrate tolerance and stunning in rabbit cardiac myocytes.
Topics: Animals; Calcium-Binding Proteins; Carbazoles; Cell Shape; Cyclic GMP-Dependent Protein Kinases; Deferoxamine; Drug Tolerance; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Models, Biological; Myocardial Contraction; Myocardial Stunning; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitroglycerin; Phosphorylation; Protein Kinase Inhibitors; Rabbits; S-Nitroso-N-Acetylpenicillamine; Up-Regulation | 2010 |
Hypoxia inducible factor-1 improves the negative functional effects of natriuretic peptide and nitric oxide signaling in hypertrophic cardiac myocytes.
Topics: Animals; Carbazoles; Cardiomegaly; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Deferoxamine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Nitric Oxide; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Up-Regulation | 2010 |